SPINEWAY (ALSPW.PA) Stock Fundamental Analysis
Europe - Euronext Paris - EPA:ALSPW - FR001400N2P2 - Common Stock
0.1776 EUR
+0 (+0.34%)
Overall ALSPW gets a fundamental rating of 3 out of 10. We evaluated ALSPW against 68 industry peers in the Health Care Equipment & Supplies industry. While ALSPW seems to be doing ok healthwise, there are quite some concerns on its profitability. ALSPW is valied quite expensively at the moment, while it does show a decent growth rate.
1. Profitability
1.1 Basic Checks
- ALSPW had negative earnings in the past year.
- ALSPW had a positive operating cash flow in the past year.
- In the past 5 years ALSPW always reported negative net income.
- In the past 5 years ALSPW always reported negative operating cash flow.
1.2 Ratios
- ALSPW's Return On Assets of -6.28% is on the low side compared to the rest of the industry. ALSPW is outperformed by 70.59% of its industry peers.
- ALSPW has a worse Return On Equity (-7.95%) than 69.12% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -6.28% | ||
| ROE | -7.95% | ||
| ROIC | N/A |
ROA(3y)-16.26%
ROA(5y)-30.05%
ROE(3y)-21.45%
ROE(5y)-42.44%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- ALSPW's Gross Margin of 71.33% is amongst the best of the industry. ALSPW outperforms 85.29% of its industry peers.
- ALSPW's Gross Margin has improved in the last couple of years.
- ALSPW does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 71.33% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.32%
GM growth 5Y16.07%
2. Health
2.1 Basic Checks
- ALSPW does not have a ROIC to compare to the WACC, probably because it is not profitable.
- The number of shares outstanding for ALSPW has been increased compared to 1 year ago.
- Compared to 5 years ago, ALSPW has more shares outstanding
- Compared to 1 year ago, ALSPW has an improved debt to assets ratio.
2.2 Solvency
- ALSPW has an Altman-Z score of 1.45. This is a bad value and indicates that ALSPW is not financially healthy and even has some risk of bankruptcy.
- ALSPW has a Altman-Z score of 1.45. This is in the lower half of the industry: ALSPW underperforms 64.71% of its industry peers.
- ALSPW has a Debt/Equity ratio of 0.06. This is a healthy value indicating a solid balance between debt and equity.
- ALSPW has a better Debt to Equity ratio (0.06) than 82.35% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.06 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 1.45 |
ROIC/WACCN/A
WACC7.02%
2.3 Liquidity
- ALSPW has a Current Ratio of 3.19. This indicates that ALSPW is financially healthy and has no problem in meeting its short term obligations.
- ALSPW's Current ratio of 3.19 is amongst the best of the industry. ALSPW outperforms 85.29% of its industry peers.
- ALSPW has a Quick Ratio of 2.04. This indicates that ALSPW is financially healthy and has no problem in meeting its short term obligations.
- Looking at the Quick ratio, with a value of 2.04, ALSPW belongs to the top of the industry, outperforming 83.82% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.19 | ||
| Quick Ratio | 2.04 |
3. Growth
3.1 Past
- ALSPW shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 99.85%, which is quite impressive.
- The Revenue has decreased by -5.46% in the past year.
- Measured over the past years, ALSPW shows a quite strong growth in Revenue. The Revenue has been growing by 18.95% on average per year.
EPS 1Y (TTM)99.85%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%95.92%
Revenue 1Y (TTM)-5.46%
Revenue growth 3Y40.7%
Revenue growth 5Y18.95%
Sales Q2Q%-14.72%
3.2 Future
- The Earnings Per Share is expected to decrease by -41.47% on average over the next years. This is quite bad
- ALSPW is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 40.08% yearly.
EPS Next Y-100.08%
EPS Next 2Y-41.47%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2Y40.08%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
- ALSPW reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
- Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ALSPW. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
- Based on the Enterprise Value to EBITDA ratio, ALSPW is valued cheaper than 97.06% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 3.38 |
4.3 Compensation for Growth
- A cheap valuation may be justified as ALSPW's earnings are expected to decrease with -41.47% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-41.47%
EPS Next 3YN/A
5. Dividend
5.1 Amount
- No dividends for ALSPW!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
EPA:ALSPW (1/14/2026, 7:00:00 PM)
0.1776
+0 (+0.34%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)10-14 2025-10-14
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap6.31M
Revenue(TTM)10.99M
Net Income(TTM)-1.90M
Analysts86.67
Price Target0.28 (57.66%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-25%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)44.44%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 0.57 | ||
| P/FCF | N/A | ||
| P/OCF | 10.9 | ||
| P/B | 0.26 | ||
| P/tB | 0.44 | ||
| EV/EBITDA | 3.38 |
EPS(TTM)-0.05
EYN/A
EPS(NY)-0.08
Fwd EYN/A
FCF(TTM)-0.02
FCFYN/A
OCF(TTM)0.02
OCFY9.17%
SpS0.31
BVpS0.67
TBVpS0.41
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -6.28% | ||
| ROE | -7.95% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 71.33% | ||
| FCFM | N/A |
ROA(3y)-16.26%
ROA(5y)-30.05%
ROE(3y)-21.45%
ROE(5y)-42.44%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.32%
GM growth 5Y16.07%
F-Score6
Asset Turnover0.36
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.06 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 1.36 | ||
| Cap/Depr | 118.46% | ||
| Cap/Sales | 12.85% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | 51.15% | ||
| Profit Quality | N/A | ||
| Current Ratio | 3.19 | ||
| Quick Ratio | 2.04 | ||
| Altman-Z | 1.45 |
F-Score6
WACC7.02%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)99.85%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%95.92%
EPS Next Y-100.08%
EPS Next 2Y-41.47%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-5.46%
Revenue growth 3Y40.7%
Revenue growth 5Y18.95%
Sales Q2Q%-14.72%
Revenue Next YearN/A
Revenue Next 2Y40.08%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y97.83%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y94.43%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y120.98%
OCF growth 3YN/A
OCF growth 5YN/A
SPINEWAY / ALSPW.PA FAQ
Can you provide the ChartMill fundamental rating for SPINEWAY?
ChartMill assigns a fundamental rating of 3 / 10 to ALSPW.PA.
Can you provide the valuation status for SPINEWAY?
ChartMill assigns a valuation rating of 1 / 10 to SPINEWAY (ALSPW.PA). This can be considered as Overvalued.
Can you provide the profitability details for SPINEWAY?
SPINEWAY (ALSPW.PA) has a profitability rating of 2 / 10.
What is the earnings growth outlook for SPINEWAY?
The Earnings per Share (EPS) of SPINEWAY (ALSPW.PA) is expected to decline by -100.08% in the next year.